Skip to main content
. 2022 Jan 24;22:36. doi: 10.1186/s12935-022-02464-7

Fig. 2.

Fig. 2

OS for patients receiving different combinations of systemic and locoregional treatments after propensity score matching. A Different cycles of PCT. B Different regimens of concurrent chemotherapy. C Single-agent platinum versus radiotherapy alone after 4–6 cycles of PCT. OS overall survival, PCT palliative chemotherapy, CCRT concurrent chemoradiotherapy, RT radiotherapy